Skip to content
Mauro Nunes

AI Strategy, Applied.

Practical perspective on AI adoption, governance, and enterprise transformation — written for leaders who need clearer thinking, not louder noise.

Read Featured Insight Explore AI Readiness

Strategic Focus Areas

Helping organizations move beyond AI experimentation toward practical value, resilient operating models, and informed leadership decisions.

AI Strategy & Roadmap

Clarifying where AI matters most, how priorities should be set, and which decisions deserve leadership attention first.

Governance & Readiness

Building the foundations for responsible adoption through clearer oversight, better controls, and stronger organizational preparedness.

Operational Realism

Understanding what enterprise AI actually requires beyond the pilot stage — from workflows and accountability to scale and reliability.

Practical Transformation

Connecting AI decisions to operating models, capability building, and measurable business value rather than isolated experimentation.

A measured, strategic approach to AI

The most useful AI thinking is rarely the loudest. It is the kind that helps leaders make better decisions under real-world constraints.

Strategy before tools

The real question is not what AI can do in theory, but where it creates durable business value in practice.

Governance as an enabler

Responsible adoption is not a brake on progress. It is what makes scale, trust, and long-term performance possible.

Pragmatism over hype

The strongest AI initiatives are grounded in execution, operating model clarity, and measurable outcomes — not inflated expectations.

Strategic Perspective

View Archive →
New Perspective
Biotech

Novartis Attributes Discovery of Novel Cancer Inhibitor to its 'Genesis' Generative Biology Platform

Novartis revealed that its proprietary AI, 'Genesis', independently hypothesized, simulated, and identified a promising new molecule for treating aggressive forms of lung cancer, a process that took only 45 days. This breakthrough validates massive R&D investment in AI and fundamentally changes the economics and speed of drug discovery, creating a new competitive benchmark for the entire pharmaceutical and biotech industries.

Supply Chain

Maersk Unveils 'Odyssey AI': The First Fully Autonomous Supply Chain Orchestrator

Maersk's new AI system is now managing 30% of its Pacific shipping routes without human intervention, dynamically rerouting ships and adjusting logistics based on real-time data from weather to port congestion. This signals a major shift from AI as an analytical tool to a fully autonomous operational core, forcing competitors to re-evaluate their own AI roadmaps and readiness for hands-off operations.

Mauro Nunes

About Mauro

Mauro Nunes writes about AI strategy, governance, and enterprise transformation from real-world experience in digital modernization, operating model change, and executive-facing innovation work.

Focus & Credentials PhD in Information Technology Sciences · AI strategy · governance · enterprise transformation
Read more about Mauro

Ready to move from AI hype to AI value?

Explore the latest strategic insights, assess your organization’s readiness, or take a more practical next step in AI adoption.

Explore AI Readiness View All Insights